Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.
about
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypesHIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsRelationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failurePublic-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland comparedExplaining adherence success in sub-Saharan Africa: an ethnographic studyAdherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East AfricaShamba Maisha: Pilot agricultural intervention for food security and HIV health outcomes in Kenya: design, methods, baseline results and process evaluation of a cluster-randomized controlled trialVisual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis.Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.Associations between the legal context of HIV, perceived social capital, and HIV antiretroviral adherence in North America.Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia.Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity.Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults.Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators.Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort.Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.Practical and conceptual challenges in measuring antiretroviral adherence.Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.Efficacy of an enhanced linkage to HIV care intervention at improving linkage to HIV care and achieving viral suppression following home-based HIV testing in rural Uganda: study protocol for the Ekkubo/PATH cluster randomized controlled trial.Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study.Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users.Efficacy of an evidence-based ARV adherence intervention in China.Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.The efficacy of a computerized assessment of medication adherence in active substance users.Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review.Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural KenyaHigher quality of life and lower depression for people on ART in Uganda as compared to a community control group.Determining factors of observance of antiretroviral treatments in Cameroon during the start-up period (2000-2002).Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis.Adherence to self-administered tuberculosis treatment in a high HIV-prevalence setting: a cross-sectional survey in Homa Bay, Kenya.Real-time adherence monitoring for HIV antiretroviral therapy.An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in UgandaRethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs.What is a missed dose? Implications for construct validity and patient adherenceAdvances in the conceptualization and measurement of Health Care Empowerment: development and validation of the Health Care Empowerment inventory.Household food insecurity associated with antiretroviral therapy adherence among HIV-infected patients in Windhoek, NamibiaPredictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settingsA simple single-item rating scale to measure medication adherence: further evidence for convergent validityImproving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV.
P2860
Q21245213-623F3FA1-BC2E-4F5F-BE62-9702F1EA6FD5Q22241321-D48DEAD0-4DD0-402F-B685-E9A182A6800CQ27003431-503D1BE8-BF33-4A97-991A-DB043EFD7471Q28473120-0DBE7C0D-E2BD-4F12-A5AB-B9E9063CA80BQ28474661-B9F256FE-28F7-419E-955E-E56A43D78A62Q28533158-CC99339A-5365-4C6B-8D25-6EC6210839FFQ28647649-F70F2204-E936-4606-80CA-5CB07CA0571FQ30391305-18EE6768-F005-453C-BB2F-83B0E0E1B8E2Q30558310-3735EAC5-C68F-4E5F-B280-AAC81C4EF523Q31125998-C5A67199-E41C-4B21-B4AD-693C5E8F9109Q33336597-4204AF10-8AAA-4BB4-A9DA-474E13B6A162Q33394513-FB6AA51D-2466-48A1-8BFF-B50F60257318Q33394593-434FDF23-25DF-4089-A56F-4F3131BC7847Q33532758-F9F685C5-26EC-46CD-9450-78145FA21B62Q33532759-55DD7ED3-6BF9-40A7-9F94-EB984CA86EF8Q33582022-188B7D0F-F036-40CF-9AC2-75FD91E80FF8Q33787631-3A30FD80-923F-4E19-9EEF-13350B7DCC91Q33835857-6173ECF8-8172-4602-B29E-DE352A9428DAQ33851716-A4A015CF-3757-4002-8F2D-5682AECB7E2DQ33864350-9F472C10-C2FC-4C82-A149-E3A7DD79A250Q33926564-82D564E5-94F1-4AAD-9CF8-18F119F9908FQ33939975-925C6C36-7AF8-4128-A63D-40540E0DD06EQ33980696-9A0767E5-3874-4C04-86BE-518991C28574Q33988155-80597D1E-60B2-4EBA-B432-1ABFE94D5CACQ34049901-BC5AE119-531B-4A49-83D4-FA30D837CD40Q34066197-CB192B7C-C06F-4CB2-8027-8F67198D45D9Q34098406-32177D4C-6E42-4C32-8823-81D83AF17D16Q34109744-F9C896BB-ED98-4565-8F3B-BA2CA96E28E1Q34145120-D8F25EE2-AF7B-4363-A1BD-94FF6C5B9282Q34149863-669831CD-FAAD-4EB6-ADDC-240D3E673F71Q34199723-E52FCBF1-AC2F-49A9-A5C7-614EE79A67A1Q34284065-A001709F-1AB5-4904-B406-F47F3214EB56Q34314648-D78A9691-2361-475D-93F1-B6CF17CA34E4Q34326620-83006239-AF8B-4B64-8BD6-A625DF3F45EBQ34427759-73A35CFA-6C0A-4F59-B090-FDAD38BFCBF1Q34429813-8298DB31-17E0-4E98-B419-67F320713788Q34430645-BE67DB48-C89C-4611-AE44-0D98A9308831Q34447758-4AC87041-6478-4D2F-A61D-99118695BA05Q34462551-D8FF7C12-C0B5-4FC5-B552-5DDC744B0EB1Q34538784-66D455B8-C921-42A9-9BB6-C42A45286C77
P2860
Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Multiple validated measures of ...... in a resource-limited setting.
@en
type
label
Multiple validated measures of ...... in a resource-limited setting.
@en
prefLabel
Multiple validated measures of ...... in a resource-limited setting.
@en
P2093
P1476
Multiple validated measures of ...... in a resource-limited setting.
@en
P2093
Cissy Kityo
Jayne Byakika-Tusiime
Jessica H Oyugi
Peter Mugyenyi
Roy Mugerwa
P304
P356
10.1097/00126334-200408150-00014
P407
P577
2004-08-01T00:00:00Z